September 19, 2025 · Form 4 insider transaction
Behbahani Ali bought 4,291 shares of Black Diamond Therapeutics, Inc. at $3.35 per share, a transaction worth $14.4K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.; The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 18, 2025.